Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for Heart Rate Control in ARDS
NCT06013319Phase 3Recruiting
- Start
- Feb 2023
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of esmolol in acute respiratory distress syndrome (ARDS). Started Feb 2023; status: recruiting.
02
Drugs
esmolol
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT06013319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06013319.